Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy. | World J Gastrointest Oncol | 2023 | 37123054 | PubTator, text mining | PubMed |
| Skeletal muscle mitochondrial interactome remodeling is linked to functional decline in aged female mice. | Nat Aging | 2023 | 37118428 | PubTator, text mining | PubMed |
| Molecular Genetic Research and Genetic Engineering of Taraxacum kok-saghyz L.E. Rodin. | Plants (Basel) | 2023 | 37111845 | PubTator, text mining | PubMed |
| A Review of the Effects of Fucoxanthin on NAFLD. | Nutrients | 2023 | 37111187 | PubTator, text mining | PubMed |
| In Vitro and In Silico Investigation of Polyacetylenes from Launaea capitata (Spreng.) Dandy as Potential COX-2, 5-LOX, and BchE Inhibitors. | Molecules | 2023 | 37110760 | PubTator, text mining | PubMed |
| Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37108109 | PubTator, text mining | PubMed |
| Pharmacologic Comparison of High-Dose Hesperetin and Quercetin on MDCK II Cell Viability, Tight Junction Integrity, and Cell Shape. | Antioxidants (Basel) | 2023 | 37107328 | PubTator, text mining | PubMed |
| Lipid Aldehydes 4-Hydroxynonenal and 4-Hydroxyhexenal Exposure Differentially Impact Lipogenic Pathways in Human Placenta. | Biology (Basel) | 2023 | 37106728 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals an Eicosapentaenoic Acid Accumulation Mechanism in a Schizochytrium sp. Mutant. | Microbiol Spectr | 2023 | 37093006 | PubTator, text mining | PubMed |
| Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis. | Ther Adv Cardiovasc Dis | 2023 | 37092838 | PubTator, text mining | PubMed |
| A Novel Mutation in the OXCT1 Gene Causing Succinyl-CoA:3-Ketoacid CoA Transferase (SCOT) Deficiency Starting with Neurologic Manifestations. | Iran J Child Neurol | 2023 | 37091464 | PubTator, text mining | PubMed |
| The role of cholesterol metabolism in tumor therapy, from bench to bed. | Front Pharmacol | 2023 | 37089950 | PubTator, text mining | PubMed |
| Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by TET2, TP53, and CBL mutations. | Sci Adv | 2023 | 37083525 | PubTator, text mining | PubMed |
| Spatial and temporal dynamics of ATP synthase from mitochondria toward the cell surface. | Commun Biol | 2023 | 37072500 | PubTator, text mining | PubMed |
| Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway. | J Cancer | 2023 | 37056396 | PubTator, text mining | PubMed |
| The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression. | Int J Mol Sci | 2023 | 37047399 | PubTator, text mining | PubMed |
| The Cytosolic Acetoacetyl-CoA Thiolase TaAACT1 Is Required for Defense against Fusarium pseudograminearum in Wheat. | Int J Mol Sci | 2023 | 37047146 | PubTator, text mining | PubMed |
| Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification. | Cancers (Basel) | 2023 | 37046804 | PubTator, text mining | PubMed |
| Overexpression of salusin‑α upregulates AdipoR2 and activates the PPARα/ApoA5/SREBP‑1c pathway to inhibit lipid synthesis in HepG2 cells. | Int J Mol Med | 2023 | 37026514 | PubTator, text mining | PubMed |
| Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression. | Sci Rep | 2023 | 37024569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=19